Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative ColitisRobert Gilmore, Jakob Begun, Wei Lian Tan et al.|Journal of Crohn s and Colitis|2023Cited by 61
Higher Anti-tumor Necrosis Factor-α Levels Correlate With Improved Radiologic Outcomes in Crohn’s Perianal FistulasMichael De Gregorio, Nik S. Ding, Tanya Lee et al.|Clinical Gastroenterology and Hepatology|2021Cited by 36
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort studyRobert Gilmore, Jakob Begun, Rupert W. Leong et al.|Intestinal Research|2024Cited by 13
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn’s diseaseRobert Gilmore, Jakob Begun, Amrutha Murali et al.|Intestinal Research|2025Cited by 8
P620 A cost-effective Inflammatory Bowel Disease flare management pathway utilising rapid access intestinal ultrasound and nurse-led triage to achieve hospital avoidance with increased patient satisfactionRichard Fernandes, Yoon‐Kyo An, Emi Khoo et al.|Journal of Crohn s and Colitis|2024Cited by 3